VIATRIS INC
VTRS·92556V106·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
VTRS (VIATRIS INC) is held by 270 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($1.1B), DAVIS SELECTED ADVISERS ($1.1B), VANGUARD CAPITAL MANAGEMENT LLC ($1B). Net institutional sentiment: Mixed. In Q1 2026, 4 members of Congress and 158 funds bought VTRS.
270
Holders
(26 Elite)
$11.4B
Total Value
58% (273)
Consensus
158 buying - 115 selling
13F: Insider & Congress:
Who's Trading
InsiderCPCampbell PaulSell $284KMar 23, 2026
InsiderSSSIMMONS DAVID SBuy $2KNov 3, 2025
InsiderLCLe Goff CorinneSell $72KSep 11, 2025
InsiderSSSIMMONS DAVID SBuy $3KAug 27, 2025
Showing 1-20 of 281
1 / 15
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer